Kinetic aids to proper chemotherapeutic scheduling: labeled nucleoside incorporation studies in vivo

Cervical epidermal growth factor-receptor (EGF-R) and serum insulin-like growth factor II (IGF-II) levels are potential markers for cervical cancer.

American journal of reproductive immunology (New York, N.Y. : 1989)·2000

Automated oxyhemoglobin dissociation curve construction to assess sickle cell anemia therapy.

Journal of the National Medical Association·2000

Up-regulation of epidermal growth factor-receptors (EGF-R) by nicotine in cervical cancer cell lines: this effect may be mediated by EGF.

American journal of reproductive immunology (New York, N.Y. : 1989)·2000

Fox Chase Network: Fox Chase Cancer Center's community hospital affiliation program.

The oncologist·2000

Three cycles versus six cycles of adjuvant paclitaxel (Taxol)/carboplatin in early stage ovarian cancer.

Seminars in oncology·2000

Focal sarcoplasmic reticulum calcium stores and diffuse inositol 1,4,5-trisphosphate and ryanodine receptors in human myometrium.

Cell calcium·2000

Cisplatin as a first-line treatment in T2 and T3 bladder carcinoma.

Cancer treatment reports·1987

IV melphalan in children.

Cancer treatment reports·1987

Interactions of methotrexate and cyclophosphamide with the pharmacokinetics of 5-fluorouracil in an animal model.

Cancer treatment reports·1987

Phase II trial of rDNA alfa 2b interferon in patients with malignant carcinoid tumor.

Cancer treatment reports·1987

Doxorubicin distribution in human breast cancer.

Cancer treatment reports·1987

Phase I study of echinomycin.

Cancer treatment reports·1987

Model-dependent transport limitations shape the in vitro evaluation of platinum-based nanotherapeutics.

Nanomedicine : nanotechnology, biology, and medicine·2026

Targeting CDC7 Overcomes Gemcitabine Resistance in Cholangiocarcinoma by Inducing Cellular Senescence.

Cancer letters·2026

Surgical cancer patients' attitudes and beliefs about cannabis at a midwest comprehensive cancer center.

Surgical oncology insight·2026

Gut microbiome-shaped chemotherapy responses across cancer types: mechanisms of resistance, biomarkers, and targeted interventions.

Frontiers in immunology·2026

Low-Dose Nivolumab in Various Cancers: A Real-World Exploratory Analysis in Resource-Constrained Settings.

Cancer reports (Hoboken, N.J.)·2026

Allocation Policy Implementation During a Severe Chemotherapy Shortage.

JAMA network open·2026

Related Experiment Videos

Kinetic aids to proper chemotherapeutic scheduling: labeled nucleoside incorporation studies in vivo

Related Concept Videos

Cervical epidermal growth factor-receptor (EGF-R) and serum insulin-like growth factor II (IGF-II) levels are potential markers for cervical cancer.

Automated oxyhemoglobin dissociation curve construction to assess sickle cell anemia therapy.

Up-regulation of epidermal growth factor-receptors (EGF-R) by nicotine in cervical cancer cell lines: this effect may be mediated by EGF.

Fox Chase Network: Fox Chase Cancer Center's community hospital affiliation program.

Three cycles versus six cycles of adjuvant paclitaxel (Taxol)/carboplatin in early stage ovarian cancer.

Focal sarcoplasmic reticulum calcium stores and diffuse inositol 1,4,5-trisphosphate and ryanodine receptors in human myometrium.

Cisplatin as a first-line treatment in T2 and T3 bladder carcinoma.

IV melphalan in children.

Interactions of methotrexate and cyclophosphamide with the pharmacokinetics of 5-fluorouracil in an animal model.

Phase II trial of rDNA alfa 2b interferon in patients with malignant carcinoid tumor.

Doxorubicin distribution in human breast cancer.

Phase I study of echinomycin.

Model-dependent transport limitations shape the in vitro evaluation of platinum-based nanotherapeutics.

Targeting CDC7 Overcomes Gemcitabine Resistance in Cholangiocarcinoma by Inducing Cellular Senescence.

Surgical cancer patients' attitudes and beliefs about cannabis at a midwest comprehensive cancer center.

Gut microbiome-shaped chemotherapy responses across cancer types: mechanisms of resistance, biomarkers, and targeted interventions.

Low-Dose Nivolumab in Various Cancers: A Real-World Exploratory Analysis in Resource-Constrained Settings.

Allocation Policy Implementation During a Severe Chemotherapy Shortage.

Related Experiment Videos

Kinetic aids to proper chemotherapeutic scheduling: labeled nucleoside incorporation studies in vivo

Related Concept Videos

Related Articles